Project Description

D-Pharm (TASE: DPRM) discovers and develops lipid-based drugs for the treatment of central nervous system disorders and cancer. The Company has developed two unique platform technologies that generate lipid–like medicines which utilize lipid specific properties and lipid-related pathways in living cells.